These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 122524)

  • 21. ["In vitro" activity of cefamandole, cefalotin, cefoxitin and cefuroxim against enterobacteria and Staphylococcus aureus isolated in hospital (author's transl)].
    Thabaut A; Durosoir JL; Saliou P
    Pathol Biol (Paris); 1979 Dec; 27(10):649-54. PubMed ID: 395496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms.
    Rahal JJ; Simberkoff MS; Kagan K; Moldover NH
    Antimicrob Agents Chemother; 1976 Apr; 9(4):595-9. PubMed ID: 817661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibacterial activity of five cephalosporins.
    Mutton KJ; Harkness JL
    Pathology; 1981 Jan; 13(1):73-7. PubMed ID: 6784093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
    Skar AG; Midtvedt T; Dahl O
    NIPH Ann; 1979 Dec; 2(2):31-40. PubMed ID: 398460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lysis if enterobacteria by cefoxitin, cefuroxime, and cephalothin.
    Goodwin CS; Hill JP
    Antimicrob Agents Chemother; 1977 Jan; 11(1):26-30. PubMed ID: 319751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
    Mascellino MT; Prignano G; Iegri F; Lorenzi A
    Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro studies of cefamandole.
    Bodey GP; Weaver S
    Antimicrob Agents Chemother; 1976 Mar; 9(3):452-7. PubMed ID: 769679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of four recently introduced cephalosporins with respect to probability of resistance in multiresistant strains of Escherichia coli, Proteus mirabilis and Klebsiella spec. (author's transl)].
    Loch R; Schröter G
    Zentralbl Bakteriol Orig A; 1979; 245(3):312-6. PubMed ID: 44785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined action of beta-lactum antibiotics against gram-negative bacilli.
    Bobrowski MM; Gebicka K; Borowski J
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(2):129-40. PubMed ID: 4199760
    [No Abstract]   [Full Text] [Related]  

  • 30. In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalothin.
    Eickhoff TC; Ehret JM
    Antimicrob Agents Chemother; 1976 Jun; 9(6):994-9. PubMed ID: 938029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta lactamase resistance of newer cephalosporins and antimicrobial effectiveness against gram-negative bacilli.
    Farrar WE; O'Dell NM
    Infection; 1977; 5(4):224-7. PubMed ID: 413793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.
    Knothe H; Shah P; Krcmery V; Antal M; Mitsuhashi S
    Infection; 1983; 11(6):315-7. PubMed ID: 6321357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative study of the activity of cefamandole and other cephalosporins and analysis of the beta-lactamase stability and synergy of cefamandole with aminoglycosides.
    Fu KP; Neu HC
    J Infect Dis; 1978 May; 137 Suppl():S38-S50. PubMed ID: 349097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteria.
    DeMaria A; Alvarez S; Klein JO; McCabe WR
    Infection; 1980; 8 Suppl 3():S 261-7. PubMed ID: 6447671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In vitro examination on antibacterial activities of broad-spectrum antibiotics against gram-negative clinical isolates (author's transl)].
    Deguchi K; Oda S; Sato Y; Ikeda Y; Nakamura T
    Jpn J Antibiot; 1975 Dec; 28(6):785-94. PubMed ID: 1104913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of moxalactam against pathogenic bacteria and its comparison with other antibiotics.
    Perrymann F; Flournoy DJ; Qadri SM
    Chemotherapy; 1983; 29(1):37-42. PubMed ID: 6219865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro evaluation of Ro 13-9904.
    Hinkle AM; Bodey GP
    Antimicrob Agents Chemother; 1980 Oct; 18(4):574-8. PubMed ID: 6778383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study of the minimum inhibiting concentration of a new cephalosporin (HR 756): comparative data with other beta-lactamic antibiotics].
    Mascellino MT; Prignano G; Iegri F; Delia S
    Boll Ist Sieroter Milan; 1981 May; 60(2):102-9. PubMed ID: 6272823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro testing of newer cephalosporins (author's transl)].
    Linzenmeier G; Rosenthal E
    Infection; 1979; 7 Suppl 2():S225-7. PubMed ID: 437897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines.
    Barry AL; Jones RN; Thornsberry C
    Am J Clin Pathol; 1983 Aug; 80(2):182-9. PubMed ID: 6881092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.